Joe Duarte highlight the breakout potential of a key Pharmaceutical ETF.
Joe Duarte sees weakness in stock indices due to overbought conditions, but due to the Fed’s ZIRP, any correction should be seen as a buying opportunity.
Joe Duarte highlights how Trimble Navigation exploited the Covid-19 altered market environment.
The Fed still has the market’s back, which means stocks can make all time highs, reports Joe Duarte.
Joe Duarte discusses the diverging fundamentals of two Healthcare stocks.
Joe Duarte breaks down the myths and opportunities in today’s Covid/Fed centric markets.
Joe Duarte shares the one stock in the semiconductor space like to outperform.
Joe Duarte explains how Fed interventions and market movement are trumping the influence of traditional economic indicators.
Joe Duarte is marching stocks with his markets, economy, life (MEL) analysis.
The Markets and the Fed’s defense of it are leading the economy, explains Joe Duarte.
While the markets are moving on phantom vaccines months away, GILD has a globally approved Covid-19 treatment, but gets no respect, writes Joe Duarte.
Technicals support an upside breakout in stocks, but equities—as we have learned—are dependent of the Fed, writes Joe Duarte.
While fears of a downturn didn’t materialize last week, stock investors need to know the Fed has their back, writes Joe Duarte.
The biotech sector could be heating up, reports Joe Duarte.
An imminent break in Joe Duarte’s 50-50 Rule could signal big trouble for stocks.
Hormel has continued to disappoint, but fundamentals are indicating it could be a strong play, reports Joe Duarte
As the traditionally sleepy summer trading season rolls into high gear, the combination of low volume and anemic liquidity from the Federal Reserve may make for a bumpy market, although in the current post new normal period there are no guarantees that seasonal patterns will remain in effect.
Here is an interesting pairs trade in the beverage sector from Joe Duarte.
While the Fed is pledged to ZIRP, its reduction of daily stimulus buying is the likely reason for Thursday’s market meltdown, reports Joe Duarte.
While Intel does not have the technology swag as the FANTAG stocks, recent developments have made it sexy again, reports Joe Duarte.